ReviewCancer biology & therapy2026

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy.

Allison Staton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.